Case Report 3. Sunitinib malate in patients with cerebellar metastases

Motzer, 2007, Sunitinib versus interferon alfa in metastatic renal-cell carcinoma, N Engl J Med, 356, 115, 10.1056/NEJMoa065044 Gore, 2007, Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of toxicity in an expanded open access trial with subpopulation analysis, J Clin Oncol, 25, 5010, 10.1200/jco.2007.25.18_suppl.5010 Unnithan, 2007, Safety of VEGF-targeted tyrosine kinase inhibitors in patients (Pts) with metastatic renal cell carcinoma (mRCC) and central nervous system (CNS) metastases, J Clin Oncol, 25 Medioni, 2007, Complete cerebral response with sunitinib for metastatic renal cell carcinoma, Ann Oncol, 18, 1282, 10.1093/annonc/mdm275 Patyna, 2007, Distribution of sunitinib and its active metabolite in brain and spinal cord tissue following oral or intravenous administration in rodents and monkeys, Eur J Cancer Suppl, 4, 21, 10.1016/S1359-6349(06)70062-3